Details for: TARO-SOLIFENACIN
Company: SUN PHARMA CANADA INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02437988 | TARO-SOLIFENACIN | SOLIFENACIN SUCCINATE | 5 MG | TABLET | ORAL |
| 02437996 | TARO-SOLIFENACIN | SOLIFENACIN SUCCINATE | 10 MG | TABLET | ORAL |
Consumer Information
This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.
What the medication is used for
RAN-SOLIFENACIN is used in the treatment of overactive bladder in adults with symptoms of frequent and urgent need to urinate (urinary frequency, urinary urgency) with urine leakage (urge urinary incontinence).
What it does
RAN-SOLIFENACIN is a urinary antispasmodic medication that helps to relax the smooth muscle of the bladder which leads to reduction of the symptoms caused by overactive bladder.
When it should not be used
You should not take RAN-SOLIFENACIN:
- If you are not able to empty your bladder (also called urinary retention).
- If you have End-Stage Kidney Disease and require dialysis.
- If you are not able to empty your stomach (also called gastroparesis).
- If you have narrow-angle glaucoma (high pressure and pain in the eyes).
- If you are allergic to solifenacin succinate or any of the other ingredients in RAN-SOLIFENACIN. See ‘What the non-medicinal ingredients are’
What the medicinal ingredient is
The medicinal ingredient in RAN-SOLIFENACIN tablet is ‘solifenacin succinate’.
What the non-medicinal ingredients are
Each RAN-SOLIFENACIN tablet contains the following inert ingredients: anhydrous lactose, corn starch, hypromellose, magnesium stearate, polyethylene glycol, red ferric oxide (10 mg), talc, titanium dioxide, and yellow ferric oxide (5 mg).
What dosage form it comes in
RAN-SOLIFENACIN is available in 5 and 10 mg tablets
Warnings and precautions
Before you use RAN-SOLIFENACIN, talk to your doctor or pharmacist if you:
- Have stomach problems affecting passage and digestion of food, or severe constipation.
- Have glaucoma.
- Have difficulty urinating, or weak urine stream.
- Have heart disease
- Have a rare heart problem called QT/QTc prolongation or family history of QT/QTc prolongation.
- Have kidney or liver problems.
- Have reduced ability to sweat.
- Are pregnant or planning to become pregnant. Women who might get pregnant should use an effective birth control method while taking RAN-SOLIFENACIN.
- Are breastfeeding or plan to breastfeed.
RAN-SOLIFENACIN should not be given to children or adolescents.
RAN-SOLIFENACIN may cause blurred vision and drowsiness. Do not drive a car, operate any machinery, or engage in any activities that require accurate vision and full attention.
In hot weather, RAN-SOLIFENACIN can cause heat prostration (fever and heat stroke due to decreased sweating). Do not stay long in a hot environment while taking the drug. If you have any symptoms of heat prostration, keep yourself cool and drink a lot of water.
Angioedema (the symptoms include swelling of the face or tongue, difficulty breathing) and anaphylactic reactions (the symptoms include hives, difficulty breathing, abdominal cramps, rapid heartbeat and feeling faint), which could be lifethreatening, have been reported in some patients taking RANSOLIFENACIN. If you experience any of these symptoms, stop taking RAN-SOLIFENACIN and see your doctor immediately.
Interactions with this medication
Before and while taking RAN-SOLIFENACIN you should tell your doctor about your other medications, even the medicine you bought without prescription, including vitamins and herbal supplements.
RAN-SOLIFENACIN is known to have drug interactions with the following drugs: Drugs known to prolong the QT/QTc interval and/or cause torsade de pointes, drugs that decrease electrolyte levels, anticholinergic drugs, drugs that stimulate the motility of the gut such as metoclopramide, ketoconazole, clarithromycin, erythromycin, diclofenac, nefazodone, verapamil.
Drinking grapefruit juice with RAN-SOLIFENACIN may increase your blood level of solifenacin.
Proper use of this medication
Usual Dose
5 mg daily. The daily dose may be increased to 10 mg following consultation with your doctor. Swallow the tablet whole with water.
RAN-SOLIFENACIN tablets can be taken with or without food.
Overdose
If you think you have taken too much RANSOLIFENACIN, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms
Missed Dose
If a dose is missed, the next tablet should be taken as planned. Doses should not be doubled to make up for a missed dose.
Side effects and what to do about them
The following side effects have been reported in clinical trials with solifenacin succinate:
Most common side effects: dry mouth and constipation
Common side effects: dry eyes, urinary retention, blurred vision, nausea, abdominal pain, indigestion, urinary tract infection.
The following side effects have been reported with the use of solifenacin succinate in worldwide post-marketing experience, although the frequency of events or a causal relationship with solifenacin succinate could not always be confirmed:
acid reflux, change in sense of taste, decreased appetite, delirium, dizziness, dry skin, fast or irregular heartbeat, feeling sleepy, glaucoma, hallucination, headache, high potassium levels, hypersensitivity reactions, intestinal blockage, itchiness, kidney ailment, liver problems, muscle weakness, nasal dryness, voice disorder, severe skin scaling and redness, itching (exfoliative dermatitis), severe skin rash, itchiness and fever (erythema multiforme), swelling in the lower limbs and vomiting.
Tell your doctor or pharmacist if you have any side effects while taking RAN-SOLIFENACIN. This includes any side effects not listed above.
| Symptom / effect | Talk to your healthcare professional Only if severe | Talk to your healthcare professional In all cases | Stop taking drug and get immediate medical help |
|---|---|---|---|
| Rare | |||
| Abdominal pain | ✔ | ||
| Constipation for more than 3 days | ✔ | ||
| Urinary retention | ✔ | ||
| Very rare | |||
| Swelling of the face or tongue, difficulty breathing | ✔ | ||
| Fast or irregular heartbeat | ✔ | ||
| Anaphylactic reactions (severe allergic reactions) | ✔ | ||
How to store
Keep RAN-SOLIFENACIN and all other medications out of the reach of children.
Store between 15°C to 30°C.
Do not keep medicine that is out of date or that you no longer need.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/healthcanada/services/drugs-health-products/medeffectcanada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345.
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
This document, plus the full product monograph prepared for health professionals, can be found by contacting Ranbaxy Pharmaceuticals Canada Inc at 1-866-840-1340.
RANBAXY
This leaflet was prepared by
Ranbaxy Pharmaceuticals Canada Inc.
Brampton ON L6T 1C1
Last revised: April 17, 2019